Using mosquito excreta to enhance mosquito-borne disease surveillance

Ana Ramírez evaluated the use of mosquito excreta as a sample type for enhancing mosquito-borne disease surveillance. She found that mosquito excreta can be used to detect pathogens and other microorganisms present in the mosquito, including viruses and parasites. Mosquito excreta can be used for field and laboratory based studies

Mosquitopia

This edited volume brings together natural scientists, social scientists and humanists to assess if (or how) we may begin to coexist harmoniously with the mosquito. The mosquito is humanity’s deadliest animal, killing over a million people each year by transmitting malaria, yellow fever, Zika and several other diseases. Yet of the 3,500 species of mosquito on Earth, only a few dozen of them are really dangerous—so that the question arises as to whether humans and their mosquito foe can learn to live peacefully with one another. Chapters assess polarizing arguments for conserving and preserving mosquitoes, as well as for controlling and killing them, elaborating on possible consequences of both strategies. This book provides informed answers to the dual question: could we eliminate mosquitoes, and should we? Offering insights spanning the technical to the philosophical, this is the “go to” book for exploring humanity’s many relationships with the mosquito—which becomes a journey to finding better ways to inhabit the natural world. Mosquitopia will be of interest to anyone wanting to explore dependencies between human health and natural systems, while offering novel perspectives to health planners, medical experts, environmentalists and animal rights advocates

Translational Research for Zoonotic Parasites: New Findings toward Improved Diagnostics, Therapy and Prevention

In this book is reported novel information on diagnosis, treatment, and control of parasites that are naturally transmitted from animal reservoirs to humans. Subjects: Public Health and Healthcare: Prevention; Medicine and Pharmacology: Therapy

Global health - a challenge for interdisciplinary research

Human, animal and plant health is a field of work which offers opportunities for inter- and trans-disciplinary research. The whole topic bridges the natural and social sciences. Today, in a world of global environmental change it is widely recognized that human societies and their wellbeing depend on a sustainable equilibrium of ecosystem services and the possibility of cultural adaptation to global environmental change. The need to identify and quantify health risks related to global environmental change is now one of the most important challenges of humankind. Describing spatial (geographic, intra/inter-population) and temporal differences in health risks is an urgent task to understand societies’ vulnerabilities and priorities for interventions better. The Göttingen International Health Network (GIHN) is a research and teaching network in relation to this cross-cutting topic. The book provides a collection of articles which contribute to this issue of overriding importance and presents an overview of the GIHN launch event

Global health

Human, animal and plant health is a field of work which offers opportunities for inter- and trans-disciplinary research. The whole topic bridges the natural and social sciences. Today, in a world of global environmental change it is widely recognized that human societies and their wellbeing depend on a sustainable equilibrium of ecosystem services and the possibility of cultural adaptation to global environmental change. The need to identify and quantify health risks related to global environmental change is now one of the most important challenges of humankind. Describing spatial (geographic, intra/inter-population) and temporal differences in health risks is an urgent task to understand societies’ vulnerabilities and priorities for interventions better. The Göttingen International Health Network (GIHN) is a research and teaching network in relation to this cross-cutting topic. The book provides a collection of articles which contribute to this issue of overriding importance and presents an overview of the GIHN launch event

Ultrasensitive detection of toxocara canis excretory-secretory antigens by a nanobody electrochemical magnetosensor assay.

peer reviewedHuman Toxocariasis (HT) is a zoonotic disease caused by the migration of the larval stage of the roundworm Toxocara canis in the human host. Despite of being the most cosmopolitan helminthiasis worldwide, its diagnosis is elusive. Currently, the detection of specific immunoglobulins IgG against the Toxocara Excretory-Secretory Antigens (TES), combined with clinical and epidemiological criteria is the only strategy to diagnose HT. Cross-reactivity with other parasites and the inability to distinguish between past and active infections are the main limitations of this approach. Here, we present a sensitive and specific novel strategy to detect and quantify TES, aiming to identify active cases of HT. High specificity is achieved by making use of nanobodies (Nbs), recombinant single variable domain antibodies obtained from camelids, that due to their small molecular size (15kDa) can recognize hidden epitopes not accessible to conventional antibodies. High sensitivity is attained by the design of an electrochemical magnetosensor with an amperometric readout with all components of the assay mixed in one single step. Through this strategy, 10-fold higher sensitivity than a conventional sandwich ELISA was achieved. The assay reached a limit of detection of 2 and15 pg/ml in PBST20 0.05% or serum, spiked with TES, respectively. These limits of detection are sufficient to detect clinically relevant toxocaral infections. Furthermore, our nanobodies showed no cross-reactivity with antigens from Ascaris lumbricoides or Ascaris suum. This is to our knowledge, the most sensitive method to detect and quantify TES so far, and has great potential to significantly improve diagnosis of HT. Moreover, the characteristics of our electrochemical assay are promising for the development of point of care diagnostic systems using nanobodies as a versatile and innovative alternative to antibodies. The next step will be the validation of the assay in clinical and epidemiological contexts